PRRUF - Aimmune's Approval And Other News: The Good Bad And Ugly Of Biopharma
Aimmune Gets a Boost as FDA Green Signals Allergy Medication
Aimmune Therapeutics (AIMT) received FDA nod for its peanut allergy medication Palforzia. This orally administered medication aims to mitigate allergic reactions caused by exposure to peanuts. While it is not designed to be an emergency treatment, the company is still looking at a lucrative market ahead for the treatment. It is estimated that there are more than 1.6 million children and teens suffering from peanut allergies in the United States alone. Palforzia is the first FDA-approved medication for treating food allergies.
Palforzia works